OVERVIEW ON ROLE OF PRIMARY CARE IN MANAGEMENT OF CHRONIC KIDNEY DISEASE

NISREEN OMAR ASRAF *

Family Medicine, National Guard Hospital, Primary Health Care (Specialized Poly Clinic), Jeddah, Saudi Arabia.

ABDULLAH WALEED BORMAH

King Abdulaziz University (KAU), Saudi Arabia.

MARYAM BAKR ALHUMUD

Dawmat Aljandal General Hospital, Saudi Arabia.

ABDULBARI ABDULKHALIQ M FELEMBAN

King Abdulaziz University (KAU), Saudi Arabia.

HASHIM MAHFOUZ A. ALQURASHI

King Abdulaziz University (KAU), Saudi Arabia.

MOHAMMED HISHAM BARDESI

King Abdulaziz University Hospital (KAUH), Saudi Arabia.

OHOUD OWAYEDH A. ALMUTAIRI

Alhada Hospital, Saudi Arabia.

AMEERA AHMAD M ALHAWSAWI

King Abdulaziz Hospital, Makkah, Saudi Arabia.

ABDULHAKEEM, ADHWAA SALEH A.

Umm Alqura University (UQU), Saudi Arabia.

ALQURASHI ،MAY AWWADH O.

Umm Alqura University (UQU), Saudi Arabia.

ABDULLAH ADIL S KAMAL

Umm Alqura University (UQU), Saudi Arabia.

ALSADI, AFNAN SULAIMAN H.

Umm Alqura University (UQU), Saudi Arabia.

FATIMA MOHAMMED A ALABBASI

Umm Alqura University (UQU), Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Chronic kidney disease (CKD) is characterised by the presence of kidney damage or an estimated glomerular filtration rate (eGFR). Patients with more advanced stage 3 or stage 4 CKD experience a higher incidence of cardiovascular events and mortality. Because chronic kidney disease is a growing health concern, family physicians must be equipped to care for this unique patient population. Practice recommendations encourage proactive care of cardiovascular risk, the side effects of metabolic bone disease, and anaemia in these individuals as well as surveillance for increasing kidney disease. Primary care physicians (PCPs) are on the front lines of identifying and treating CKD as early as possible. However, the majority of PCPs frequently miss the existence of CKD. Additionally, the majority of patients with stages 3 and 4 CKD are not co-managed by nephrologists, despite the fact that increasing nephrologists' engagement in the care of these patients has been associated with improved dialysis-free survival. Early detection and treatment of these issues can stop the onset of subsequent sequelae, thus they shouldn't wait till nephrology is involved. This patient population also need appropriate counselling and health maintenance, both of which should be provided by the family doctor overseeing the patient's care.

Keywords: Primary care, CKD, albuminuria, co-morbidities, kidney failure


How to Cite

ASRAF, N. O., BORMAH, A. W., ALHUMUD, M. B., FELEMBAN, A. A. M., ALQURASHI, H. M. A., BARDESI, M. H., ALMUTAIRI, O. O. A., ALHAWSAWI, A. A. M., SALEH A., A. A., AWWADH O., A. ،MAY, KAMAL, A. A. S., SULAIMAN H., A. A., & ALABBASI, F. M. A. (2022). OVERVIEW ON ROLE OF PRIMARY CARE IN MANAGEMENT OF CHRONIC KIDNEY DISEASE. UTTAR PRADESH JOURNAL OF ZOOLOGY, 43(24), 170–176. https://doi.org/10.56557/upjoz/2022/v43i243311

Downloads

Download data is not yet available.

References

Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. Journal of General Internal Medicine. 2011;26(4): 386–392.

Available: https://doi.org/10.1007/s11606-010-1523-6

Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007;298(17):2038–2047. doi: 10.1001/jama.298.17.2038.

K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

K/DOQI Clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(4 Suppl 3):S1–91.

Matsushita K, Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081.

DOI: 10.1016/S0140-6736(10)60674-5. [

Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–147.

Zandi-Nejad K, Brenner BM. Strategies to retard the progression of chronic kidney disease. Med Clin North Am. 2005;89(3):489–509.

DOI: 10.1016/j.mcna.2004.11.001

Vaidya SR, Aeddula NR. Chronic Renal Failure. [Updated 2022 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.

Available:https://www.ncbi.nlm.nih.gov/books/NBK535404/

Mitra PK, Bradley JR. Chronic kidney disease in primary care. Journal of the Royal Society of Medicine. 2007;100(1):40–45.

Availale:https://doi.org/10.1177/014107680710000115

Pradeep Arora, et al. chronic kidney disease (CKD). Medscape 2021.

Available:https://emedicine.medscape.com/article/238798

Fraser, S. D., & Blakeman, T. (2016). Chronic kidney disease: identification and management in primary care. Pragmatic and observational research, 7, 21–32.

Available: https://doi.org/10.2147/POR.S97310

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–1270.

Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.

Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the kidney early evaluation program (KEEP) Am J Kidney Dis. 2010;55(3 suppl 2):S23–S33.

Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385(9987): 2616–2643.

Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365(9456):331–340. [PubMed] [Google Scholar

Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–2593.

Radhakrishnan J, Remuzzi G, Saran R, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int. 2014;86(2):246–250.

Kerr M, Bray B, Medcalf J, O’Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(suppl 3):iii73–iii80.

Rosenberg M, Kalda R, Kasiulevicius V, Lember M. Management of chronic kidney disease in primary health care: position paper of the European Forum for primary care. Quality in primary Care. 2008;16(4): 279-294.

ERA-EDTA registry annual report. www.era-edta-reg. org/index.jsp?P = annrep (accessed 9 April 2008).

Finnish Registry for Kidney Diseases.

Available: www.musili.fi/ fin/munuaistautirekisteri/finnish_registry_for_kidney_ diseases (accessed 9 April 2008).

United States Renal Data System. www.usrds.org (accessed 9 April 2008).

UK Renal Registry. www.renalreg.com (accessed 9 April 2008).

Vest BM, York TR, Sand J, Fox CH, Kahn LS. Chronic Kidney Disease Guideline Implementation in Primary Care: A Qualitative Report from the TRANSLATE CKD Study. Journal of the American Board of Family Medicine : JABFM. 2015;28(5):624–631.

Available:https://doi.org/10.3122/jabfm.2015.05.150070

Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1): 20-9.

Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate?. Clin Chem. 2002;48(5):699-707.

Lemoine S, Panaye M, Pelletier C, Bon C, Juillard L, Dubourg L, et al. Cystatin C-Creatinine Based Glomerular Filtration Rate Equation in Obese Chronic Kidney Disease Patients: Impact of Deindexation and Gender. Am J Nephrol. 2016;44 (1): 63-70.